8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)
Published . Updated .
Filed: 2026-10-06 AccNo: 0001140361-26-038818 Size: 10 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- RCKT Rocket Pharmaceuticals
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-06 AccNo: 0001140361-26-038818 Size: 10 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant It…
Source: sec-edgar
The price since 7 Oct 2026: Rocket Pharmaceuticals (RCKT) versus the S&P 500
Since the first closing price after “8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer),” Rocket Pharmaceuticals (RCKT) is -15.05%. The S&P 500 fund (SPY) is -0.94% over the same days, a -14.11% difference versus the market.
Who gains and who loses around Rocket Pharmaceuticals (RCKT)
Companies carried with this story
- RCKT Rocket Pharmaceuticals
Rocket Pharmaceuticals (RCKT) is linked, with no stored direction, high confidence in the 7 Oct 2026 story “8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> RCKT
- XPH State Street Spdr S&P Pharmaceuticals Etf
State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence in the 7 Oct 2026 story “8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer).” Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)” reaches Rocket Pharmaceuticals (RCKT)
On 7 Oct 2026, “8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)” is the story that connects Rocket Pharmaceuticals (RCKT) to this story.
For Rocket Pharmaceuticals (RCKT), the reason on file says SEC 8-K filing -> direct issuer disclosure -> RCKT
A second company, State Street Spdr S&P Pharmaceuticals Etf (XPH), is listed for a different reason: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Rocket Pharmaceuticals (RCKT) price range
RCKT traded between 2.17 and 3.40 across 20 sessions. The latest close on file is 2.23. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
How strong the case is around Rocket Pharmaceuticals (RCKT)
21 out of 100
“8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.